Tissue Regenix Group Plc (TRX) — Tangible Net Worth Ratio
Tissue Regenix Group Plc (TRX) has a Tangible Net Worth Ratio of 43.0% as of June 2025. This metric is calculated by deducting intangible assets (GBX16.31 Million) from net assets (GBX28.62 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Tissue Regenix Group Plc (TRX) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tissue Regenix Group Plc Tangible Net Worth Ratio (2007–2024)
This chart shows how Tissue Regenix Group Plc's Tangible Net Worth Ratio has changed across 20 annual periods from 2007 to 2024. As of June 2025, the ratio stands at 43.0%, reflecting net assets of GBX28.62 Million with intangible assets of GBX16.31 Million GBX. For live market cap and overall valuation, see TRX company net worth.
Annual Tangible Net Worth Ratio for Tissue Regenix Group Plc (2007–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Tissue Regenix Group Plc from 2007 to 2024, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore TRX capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.6% | GBX29.06 Million | GBX4.18 Million | GBX45.35 Million | ▼ -8.9 pp |
| 2023 | 94.5% | GBX29.36 Million | GBX1.62 Million | GBX43.24 Million | ▲ +44.0 pp |
| 2022 | 50.5% | GBX25.27 Million | GBX12.52 Million | GBX38.27 Million | ▼ -4.4 pp |
| 2021 | 54.9% | GBX24.65 Million | GBX11.12 Million | GBX34.13 Million | ▼ -5.9 pp |
| 2020 | 60.7% | GBX27.85 Million | GBX10.93 Million | GBX36.73 Million | ▲ +33.9 pp |
| 2019 | 26.8% | GBX24.59 Million | GBX18.00 Million | GBX30.50 Million | ▼ -12.0 pp |
| 2018 | 38.8% | GBX32.57 Million | GBX19.94 Million | GBX37.66 Million | ▼ -49.1 pp |
| 2018 | 87.9% | GBX39.52 Million | GBX4.80 Million | GBX45.76 Million | ▲ +36.7 pp |
| 2017 | 51.2% | GBX39.52 Million | GBX19.30 Million | GBX45.76 Million | ▼ -44.1 pp |
| 2016 | 95.2% | GBX11.54 Million | GBX550.00K | GBX13.60 Million | ▼ -4.8 pp |
| 2016 | 100.0% | GBX30.25 Million | GBX0.00 | GBX33.04 Million | ▲ +0.0 pp |
| 2015 | 100.0% | GBX11.58 Million | GBX0.00 | GBX12.67 Million | ▲ +0.0 pp |
| 2014 | 100.0% | GBX31.30 Million | GBX0.00 | GBX33.13 Million | ▲ +0.0 pp |
| 2013 | 100.0% | GBX38.64 Million | GBX0.00 | GBX39.73 Million | ▲ +0.0 pp |
| 2012 | 100.0% | GBX43.78 Million | GBX0.00 | GBX44.80 Million | ▲ +0.0 pp |
| 2011 | 100.0% | GBX9.84 Million | GBX0.00 | GBX10.24 Million | ▲ +0.0 pp |
| 2010 | 100.0% | GBX3.67 Million | GBX0.00 | GBX3.72 Million | ▲ +0.0 pp |
| 2009 | 100.0% | GBX3.63 Million | GBX0.00 | GBX3.70 Million | ▲ +21.9 pp |
| 2008 | 78.1% | GBX9.68 Million | GBX2.12 Million | GBX9.77 Million | ▼ -21.9 pp |
| 2007 | 100.0% | GBX5.74 Million | GBX0.00 | GBX5.75 Million | — |